Variation in Supportive Care Practices in Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 11, 2008, Pages 1231-1238

  Lee, Stephanie J ^a   Astigarraga, Claudia C ^a   Eapen, Mary ^b   Artz, Andrew S ^c   Davies, Stella M ^d   Champlin, Richard ^e   Jagasia, Madan ^f   Kernan, Nancy A ^g   Loberiza Jr , Fausto R ^h   Bevans, Margaret ⁱ   Soiffer, Robert J ^j   Joffe, Steven ^j  

^a Fred Hutchinson Cancer Research Center   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j DANA FARBER CANCER INSTITUTE   (United States)

more..

Author keywords

Allogeneic stem cell transplantation; Autologous stem cell transplantation; Practice variation; Supportive care

Indexed keywords

ANTIFUNGAL AGENT; GROWTH FACTOR;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CARDIOVASCULAR SYSTEM EXAMINATION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFORMED CONSENT; INTERNET; INTERVENTION STUDY; LUNG EXAMINATION; MALE; MEDICAL PRACTICE; MYELOABLATIVE CONDITIONING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CARE PLANNING; PATIENT MONITORING; PSYCHOSOCIAL CARE; REDUCED INTENSITY CONDITIONING; STANDARDIZATION; STATISTICAL ANALYSIS; SUPPORTIVE CARE PRACTICE;

ADULT; AGED; DATA COLLECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; SURGICAL PROCEDURES, ELECTIVE;

EID: 53749104934     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.08.008     Document Type: Article

References (34)

1. Smith T.J., Khatcheressian J., Lyman G.H., et al. 2006 Update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24 (2006) 3187-3205
2. Dekker A., Bulley S., Beyene J., Dupuis L.L., Doyle J.J., and Sung L. Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J Clin Oncol 24 (2006) 5207-5215
3. Marr K.A., Seidel K., Slavin M.A., et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 96 (2000) 2055-2061
4. Ohashi K., Tanabe J., Watanabe R., et al. The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. Am J Hematol 64 (2000) 32-38
5. Ruutu T., Eriksson B., Remes K., et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 100 (2002) 1977-1983
6. Thornley I., Lehmann L.E., Sung L., et al. A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 10 (2004) 635-644
7. Tay J., Tinmouth A., Fergusson D., Huebsch L., and Allan D.S. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13 (2007) 206-217
8. Poe S.S., Larson E., McGuire D., and Krumm S. A national survey of infection prevention practices on bone marrow transplant units. Oncol Nurs Forum 21 (1994) 1687-1694
9. Kruger W.H., Hornung R.J., Hertenstein B., et al. Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res 10 (2001) 895-903
10. Lee S.J., Joffe S., Artz A.S., et al. Individual physician practice variation in hematopoietic cell transplantation. J Clin Oncol 26 (2008) 2162-2170
11. Parimon T., Madtes D.K., Au D.H., Clark J.G., and Chien J.W. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med 172 (2005) 384-390
12. Coghlan J.G., Handler C.E., and Kottaridis P.D. Cardiac assessment of patients for haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 20 (2007) 247-263
13. Joffe S., Mello M.M., Cook E.F., and Lee S.J. Advance care planning in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant 13 (2007) 65-73
14. Ganti A.K., Lee S.J., Vose J.M., et al. Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning. J Clin Oncol 25 (2007) 5643-5648
15. Jacoby L.H., Maloy B., Cirenza E., Shelton W., Goggins T., and Balint J. The basis of informed consent for BMT patients. Bone Marrow Transplant 23 (1999) 711-717
16. Benedict J.M., Simpson C., and Fernandez C.V. Validity and consequence of informed consent in pediatric bone marrow transplantation: the parental experience. Pediatr Blood Cancer 49 (2007) 846-851
17. Loberiza Jr. F.R., Rizzo J.D., Bredeson C.N., et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 20 (2002) 2118-2126
18. Hoodin F., Kalbfleisch K.R., Thornton J., and Ratanatharathorn V. Psychosocial influences on 305 adults' survival after bone marrow transplantation; depression, smoking, and behavioral self-regulation. J Psychosom Res 57 (2004) 145-154
19. Setting CoPStCPFiaC. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs (2008), National Academies Press, Washington, DC
20. Loberiza Jr. F.R., Zhang M.J., Lee S.J., et al. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood 105 (2005) 2979-2987
21. Couriel D., Carpenter P.A., Cutler C., et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 12 (2006) 375-396
22. Russell J.A., Poon M.C., Jones A.R., Woodman R.C., and Ruether B.A. Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease. Lancet 339 (1992) 38-40
23. Russell J.A., Chaudhry A., Booth K., et al. Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: a 10-year experience. Biol Blood Marrow Transplant 6 (2000) 109-114
24. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 49 (2000) 1-125 CE1-7
25. Mank A., and van der Lelie H. Is there still an indication for nursing patients with prolonged neutropenia in protective isolation?. An evidence-based nursing and medical study of 4 years experience for nursing patients with neutropenia without isolation. Eur J Oncol Nurs 7 (2003) 17-23
26. Hayes-Lattin B., Leis J.F., and Maziarz R.T. Isolation in the allogeneic transplant environment: how protective is it?. Bone Marrow Transplant 36 (2005) 373-381
27. Smith G.C., and Pell J.P. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 327 (2003) 1459-1461
28. Zerbe M.B., Parkerson S.G., and Spitzer T. Laminar air flow versus reverse isolation: nurses' assessments of moods, behaviors, and activity levels in patients receiving bone marrow transplants. Oncol Nurs Forum 21 (1994) 565-568
29. Gaskill D., Henderson A., and Fraser M. Exploring the everyday world of the patient in isolation. Oncol Nurs Forum 24 (1997) 695-700
30. Sasaki T., Akaho R., Sakamaki H., et al. Mental disturbances during isolation in bone marrow transplant patients with leukemia. Bone Marrow Transplant 25 (2000) 315-318
31. Cohen M.Z., Ley C., and Tarzian A.J. Isolation in blood and marrow transplantation. West J Nurs Res 23 (2001) 592-609
32. Woolf S.H. The meaning of translational research and why it matters. JAMA 299 (2008) 211-213
33. Ruutu T., Niederwieser D., Gratwohl A., and Apperley J.F. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT. Bone Marrow Transplant 19 (1997) 759-764
34. Ruutu T., Hermans J., van Biezen A., Niederwieser D., Gratwohl A., and Apperley J.F. How should corticosteroids be used in the treatment of acute GVHD? EBMT Chronic Leukemia Working Party. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 22 (1998) 614-615